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Abstract: With the recent technological and computational advancements, structural biology has
begun to tackle more and more difficult questions, including complex biochemical pathways and
transient interactions among macromolecules. This has demonstrated that, to approach the complexity
of biology, one single technique is largely insufficient and unable to yield thorough answers, whereas
integrated approaches have been more and more adopted with successful results. Traditional
structural techniques (X-ray crystallography and Nuclear Magnetic Resonance (NMR)) and the
emerging ones (cryo-electron microscopy (cryo-EM), Small Angle X-ray Scattering (SAXS)), together
with molecular modeling, have pros and cons which very nicely complement one another. In this
review, three examples of synergistic approaches chosen from our previous research will be revisited.
The first shows how the joint use of both solution and solid-state NMR (SSNMR), X-ray crystallography,
and cryo-EM is crucial to elucidate the structure of polyethylene glycol (PEG)ylated asparaginase,
which would not be obtainable through any of the techniques taken alone. The second deals with the
integrated use of NMR, X-ray crystallography, and SAXS in order to elucidate the catalytic mechanism
of an enzyme that is based on the flexibility of the enzyme itself. The third one shows how it is
possible to put together experimental data from X-ray crystallography and NMR restraints in order to
refine a protein model in order to obtain a structure which simultaneously satisfies both experimental
datasets and is therefore closer to the ‘real structure’.
Keywords: integrative structural biology; X-ray crystallography; solution NMR; SSNMR; SAXS;
cryo-EM
1. The Importance of Integrated Structural Biology
The elucidation of the structural features of macromolecules by X-ray and NMR has had a
great impact on the research in chemistry, biology, and medicine. Today, the scientific and technical
progress has allowed for expanding the capability for structural biology to investigate systems not
accessible, so far, to conventional methodologies and to characterize the dynamic processes and
transient interactions both inside and outside the cell [1–8].
Problems concerning crystallization [9], the size of the macromolecule [10,11] to study, and the
heterogeneity of the sample are no more obstacles to the structural characterization. X-ray diffraction
and NMR are still the largest contributors to the field, but electron microscopy is gathering pace. At the
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same time, NMR spectroscopy has also undergone technical and methodological advancements now
allowing for the characterization of difficult systems such as very large or transient protein complexes,
fibrils, and protein embedded in matrices [12–15].
However, the complexity of the biological systems is such that none of these methodologies alone
can provide a full picture of the structural, dynamical, and functional properties that are of relevance
to biology [16,17]. The integration of the different biophysical methodologies with the support of
the computational methods is thus clearly the strategy of choice to deal with the most interesting
biological macromolecules and pathways [18]. This approach has proven to be efficient also in the
characterization of synthetic and semi-synthetic macromolecules designed as drugs or drug candidates
and to investigate processes where macromolecules rapidly sample multiple conformations. In other
cases, the simple knowledge of the three-dimensional structure of a biomolecule is not enough for
understanding the mechanism of the biological process in which the biomolecule is involved.
We will here revisit three cases taken from some recent research in our laboratory that allow to
further stress the importance and the power of such an integrated approach.
1.1. The Characterization of polyethylene glycol (PEG)ylated l-Asparaginase Suggests a Strategy
for the Investigation of ‘Coated Biologics’
One of the major targets in nanomedicine is the development of nanocarriers to deliver drugs to
specified locations. Despite in vitro experiments carried out using the drug-loaded nanocarriers being
successful, the efficiency of these drug carriers in vivo is not encouraging as they fail to reach their target.
This efficiency depends on the route of administration, on the preferential uptake by non-target cells,
on the lifetime of the carrier within the biological system, and on the ability of the nanocarrier to escape
the immune system response to its presence. The number of approved biological drugs against several
diseases [19,20] is increasing. Some of them have been investigated by X-ray crystallography [21–23],
NMR spectroscopy [24], and, more recently, by cryo-electron microscopy (Cryo-EM) [25] to obtain
structural information potentially useful in their optimization by rational design.
For this reason, the characterization of “stealth biologics”, which are able to efficiently reach
their target, is an attractive area of research, is becoming a must for the approval of new biologics
by the authorities [26–29], and is an illuminating example of the great opportunities provided by the
integration of the different biophysical methodologies. Example “stealth biologics” are cytokines,
enzymes, and growth factors conjugated with chains of polyethylene glycol (PEG) to improve the
pharmacokinetic properties and lower the immunogenicity. In particular, the coating of proteins
with PEG is used to produce “stealth biologics” largely invisible to the immune system, stable to the
enzymatic hydrolysis, and with a reduced renal clearance.
However, PEGylation is a challenge for structural biologist: (1) It inhibits the crystallization of
the protein [30], (2) causes serious problems to the standard structural biology techniques [31–35],
and (3) limits the use of solution NMR to the small proteins because it significantly increases the
hydrodynamic volume of the protein itself [30,36–39]. Therefore, it is not possible to obtain information
at the atomic level to drive any possible structure-based optimization processes using only a single
biophysical method.
Recently, we have shown that the integration of NMR and X-ray crystallography allows for the
obtainment of an experimental and reliable structure of a large PEGylated protein [33].
Our group has recently reported high quality solid-state NMR spectra (SSNMR) of some PEGylated
proteins [37]. The comparison of 13C-13C two-dimensional SSNMR spectra collected on some native
proteins and on their PEGylated forms proves that in all cases 3-D structure of the protein core is
preserved after conjugation with PEG [37]. One of these, l-asparaginase II (ANSII), is currently used
as native enzyme or in its PEGylated form to induce l-asparagine depletion in patients with acute
leukemia [40,41]. The tetrameric structure of the native enzyme was revealed by X-ray crystallography.
The four identical monomers (326 amino acids) are organized to form a dimer of dimers of 138 kDa
with a D2 symmetry [23]. The conjugation of the exposed lysines with short PEG chains (of about
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1 kDa) does not allow the collection of NMR spectra in solution on the tetrameric protein. Conversely,
the presence of the PEG chains does not prevent the collection of SSNMR spectra on rehydrated sample
of the protein to perform resonance assignment and to obtain structural restraints.
Taking into account the complexity of the problem, experimental data obtained from different
biophysical methodologies were analyzed following an integrated approach to properly characterize
this PEGylated protein [2,42].
To characterize these large PEGylated proteins/complexes, we relied upon a combined use of
solution NMR and X-ray crystallography and solid-state NMR experiment collected on the conjugated
l-asparaginase. Here, the previous analysis was complemented with cryo-EM data to further validate
the structural models calculated by the experimental restraints.
The used strategy has been the following: (i) 2D SSNMR spectra was recorded on the same batch
of crystals used to solve the X-ray structure of l-asparaginase II and on rehydrated samples of the
PEGylated protein in the form of a sediment; (ii) the two sets of SSNMR spectra are compared for a
first structural assessment; (iii) solution NMR spectra on a deuterated sample of l-asparaginase II
was collected to assign the protein regions retaining a large mobility; (iv) 2D and 3D SSNMR spectra
were collected on crystalline and PEGylated samples of the protein to complete an extensive resonance
assignment, integrating the data collected in solution; (v) structural restraints are derived from 13C-13C
two-dimensional SSNMR spectra to confirm the fold of both the native protein in solution and of
its PEGylated form; (vi) a restraints-driven docking calculation is used to generate a representative
structural model that is compared to 2D classes from cryo-EM and validated using the residual dipolar
couplings (RDCs) collected in solution using a filamentous phages Pf1 as alignment medium on the
free protein (Scheme 1).
Scheme 1. Schematic representation of the integrated approach used for the structural characterization
of polyethylene glycol (PEG)ylated l-asparaginase II (ANSII).
PEGylation of ANSII does not appear to alter the overall architecture of the protein, as shown in
the Cryo-EM 2D classes derived from native as well as PEGylated ANSII particles (see Figure S1). Both
sets of 2D classes show particles of around 9 nm in length and 7 nm in width, compatible with the size
of the ANSII tetramer. Interestingly, the presence of PEG does not affect the Cryo-EM determination of
the overall protein shape.
Collectively, NMR and Cryo-EM data demonstrate that the PEGylated ANSII retains the quaternary
structure of the native enzymes. Moreover, structural model with the lowest haddock-score calculated
starting from the restraints derived from the SSNMR spectra agrees with the RDCs collected on the
native protein in solution (Table S1 and Figure S2A). For this reason, RDCs were added directly in the
HADDOCK calculation in order to obtain a more accurate [43,44] structural model of PEG-ANSII in
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better agreement with all the collected experimental data (Figure 1). The calculation was repeated
using inter-monomer distance restraints from SSNMR for the PEGylated protein together with the
RDCs evaluated in solution on the free protein. Models obtained by including RDCs in HADDOCK
calculations showed improved statistics compared to the models obtained using solely the SSNMR
restraints (see Table S1, Table S2 and Figure S2). Furthermore, the calculated model is in agreement
with the Cryo-EM 2D classes.
Figure 1. (A) Enlargement of two regions of the 2D 13C-13C DARR (Dipolar Assisted Rotational
Resonance) solid-state NMR (SSNMR) spectrum (mixing time 200 ms) displaying long-range
inter-residue restraints (blue interdimer and green interdomain/intramonomer). (B) Representation of
the 21 intermonomer distance restraints used in HADDOCK calculations. Ten of these restraints define
the interface between the two monomers (chains A and C in wheat and pink, respectively) forming the
intimate dimer, whereas eleven define the interface between other two monomers (chains A and D in
wheat and light-blue, respectively). The restraints were replicated according to the protein symmetry.
(C) Structural model with the lowest energy obtained with HADDOCK calculations, implementing
SSNMR experimental restraints and residual dipolar couplings (RDCs) restraints. The PEG chains are
schematized as white spheres. (D) Cryo-electron microscopy (cryo-EM) 2D classes of ANSII PEGylated
with PEG 5000. The figure is an adaptation from Reference [21].
To date, there is still an open debate on the preservation of the protein structure after conjugation
with large polymers. The use of this integrated strategy extends the possibility of structural biology to
characterize these challenging systems with potential benefits for molecular pharmacology.
1.2. Integrated Analysis of the Molecular Mechanism of Collagen Proteolysis by Matrix
Metalloproteinase-1 (MMP-1)
Several enzymes are multidomain proteins which carry out their catalytic activity by sampling
multiple conformations. The identification of the conformations adopted by the enzyme in solution
is required to describe in detail the catalytic mechanism. One significant example is represented by
MMP-1 which, in its active form, is constituted by a catalytic and a hemopexin-like domain connected
by a flexible linker. The isolated catalytic domain retains its hydrolytic activity against non-structured
peptides but the degradation of highly structured substrates (i.e., collagen type I) requires the presence
of the hemopexin-like domain.
In this example, we show that the integration of experimental restraints and computational
methods can provide hints on the predominant conformations sampled by proteins in solution. Matrix
metalloproteinases (MMPs) are a family of enzymes designed by nature to hydrolyze a variety of large
proteins of the extracellular matrix [45,46]. MMPs have been evolved towards a broad proteolytic
activity. At the same time the presence and activity of the enzyme are strictly regulated. As a result,
the recognition and hydrolysis of a variety of substrates can be obtained by the interplay between high
specialization of protein domains and protein interdomain flexibility [47]. The majority of MMPs’ active
forms, including MMP-1, encompass two-domains, a catalytic (CAT) and a hemopexin-like (HPX)
one, which can hydrolyze highly complex substrates, such as the triple-helical, interstitial (types I-III)
collagen [48]. The substrate is much larger in size than the enzyme active cleft. Therefore, interdomain
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flexibility plays a crucial role in the catalytic mechanism: Interdomain rearrangements allows both
the movement of the MMP along collagen fibrils and the untwisting/perturbation of the collagen
helix, which is required for the positioning of a single peptide chain into the active site [47,49–55].
An accurate estimate of the most likely conformations in solution by the multidomain enzyme is thus
required to explain the basis of substrate recognition and collagen hydrolysis at the molecular level.
Experimental paramagnetic NMR spectroscopy and small angle X-ray scattering (SAXS) have been
thus exploited to calculate the maximum occurrence (MO) of MMP-1 conformations (vide infra).
When a system is able to sample multiple conformations on the timescale of the experiment,
the experimental data correspond to the weighted average of the “experimental observable” that
would be observed for each conformation if the system was only sampling that specific conformation.
To calculate the ensemble that is giving rise to a particular averaged observable is an “ill-posed inverse
problem” that permits a number of plausible solutions [56,57]. A vast collection of methods, ranging
from the identification of the sparsest ensembles to the maximum entropy reweighting [56–95] have
been proposed to generate ensembles in agreement with the experimental data. Among those, in our
laboratory a new method was developed aimed at identifying which are the conformations that
are more likely accessed by the system. The method is called maximum allowed probability or
Maximum Occurrence [80,96–98] and has the advantage of providing a mathematically correct upper
bound to the population of a given conformation: The Maximum Occurrence (MaxOcc) of a given
conformation or regions of conformations is defined and computed as the maximum weight that this
conformation/region can acquire in any suitable ensemble while still preserving the ensemble’s ability
to reproduce the experimental data. The MaxOcc approach was preferred over Maximum Entropy
because of the unavailability of extensive MD trajectories to be reweighted.
The MMP-1 conformations showing large MaxOcc values (up to 47%) are restricted into a relatively
small structural region and are greatly different from the closed MMP-1 structures determined by
single crystal X-ray crystallography. The MaxOcc of the latter is around 20%, which is somehow the
upper limit for the existence of this conformation in the ensemble sampled by the protein in solution.
In all the high MaxOcc conformations, the catalytic and hemopexin domains are not in close contact.
Furthermore, the residues of the HPX domain that are responsible for the binding to the collagen are
solvent exposed and ready to interact with the substrate. The MaxOcc analysis indicates that MMP-1
in solution is supposed to establish interactions with collagen and then to proceed steadily through the
steps of collagenolysis (Figure 2) [99].
Figure 2. Modeling of the steps preceding the mechanism of collagenolysis. From left to right, one of
the structures with the highest Maximum Occurrence (MaxOcc), two morphing intermediates, and the
structure of the first step of the mechanism of collagenolysis. In yellow is the surface representation
of matrix metalloproteinase-1 (MMP-1), in blue is the MMP consensus sequence HEXXHXXGXXH,
in orange is the MMP-1 catalytic Zn2+, in green is the surface of a triple helical peptide model (THP)
representative of collagen type I, and in blue is the THP cleavage site (Gly-Ile) of the first chain. The blue
and red arrows indicate the directions of helices hA and hC, respectively, to facilitate visualizing the
movement of the catalytic (CAT) domain with respect to the hemopexin-like (HPX) domain and the
THP. The THP sequence is (GPO)4-GPQGIAGQRGVVGLO-(GPO)4 (where O is 4-hydroxyproline),
based on the human α1(I) collagen chain. Adapted from Reference [100].
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1.3. Integrating X-Ray and NMR Experimental Data
It is well known that combining different structural biology techniques can compensate for each
other’s weaknesses or limitations. While “you cannot teach the eyes to hear or the ears to see” a more
complete picture, which not only explains all the data but has also the possibility of highlighting
hidden discrepancies, is obtained by the combination of different techniques [16].
NMR data, and in particular residual dipolar couplings, are precisely sensitive to the local features.
The structural information about the overall shape of the molecule becomes accessible only if an
increasing number of short-range data are included and with prior information about geometries.
X-ray reflections encode primarily the information about the overall shape and can access the atomic
details only when the number of high quality reflections at high resolutions increases. However, even
at the highest resolutions, X-ray diffraction remains intrinsically poorly sensitive to local details.
NMR and X-ray diffraction have been presented historically in contrast to one another. Indeed,
it is often the case that crystal structures and NMR data are not in agreement with one another.
However, it has to be stressed that not in every case discrepancy is significant. This originates from
the connate inaccuracy on short-range distances of X-ray crystallography, mainly when it comes to
the determination of the position of hydrogen atoms, which are, on the contrary, the bulk of NMR
experimental data. A very remarkable paper by Zweckstetter and Bax suggested that the inconsistency
should be somehow “weighted” based on the X-ray data resolution and thus coined the term “structural
noise” [100]. On passing, we note that the concepts reported in reference [100] had been dramatically
overlooked by the NMR community, and this contributed to create the myth that it is most often the
case that X-ray and NMR do not to agree. On the contrary, joint X-ray/NMR refinement has shown to
be a very efficient way to reveal if discrepancies are real or merely due to structural noise. Recently,
we have implemented the use of NMR restraints [101] into one of the most popular crystallographic
refinement software, i.e., REFMAC [102,103] (which has been used to refine 42.7% of all the X-ray
depositions in the PDB as of August 2019), and we have applied it to a number of examples [4,101,104].
We here report the results of REFMAC-NMR calculations performed on two proteins that are
extremely well characterized by NMR spectroscopy: Ubiquitin and GB3 (Figure 3). Especially in the
case of ubiquitin, the apparent discrepancy between the X-ray structure and the NMR data (Figure 3,
panel a) have been attributed to protein mobility [63,66]. However, a less strict interpretation of
the X-ray structure demonstrated that the NMR data are largely compatible with a very limited
mobility [105], and REFMAC-NMR clearly confirms this observation [101].
REFMAC-NMR was further modified so as to include a-priori knowledge of the specific system
properties with the aim of decreasing the amount of data needed to achieve a more comprehensive
scenario. In order to reinforce the efficiency of NMR for refining a multisubunit or multidomain
system, it is possible to introduce constraints among the tensors used to fit the experimental data of the
different domains or subunits. Differences in tensors can be due either to a rearrangement between the
X-ray and the NMR structure or to the fact that different samples with different labeling patterns are
used to minimize the complexity of NMR spectra. This allows for reducing the number of unknowns
to which to fit the experimental data. It also allows for the improvement of the quality of refinements
even when the experimental data cannot guarantee to accurately measure all the parameters, especially
in those cases in which sizeable interdomain rearrangement is observed between the solution and
the crystal [101].
The use of REFMAC-NMR shows that quite often NMR and X-ray data can be brought together
to a single structure without calling in mobility issues [101].
We can conclude that joint refinement results in more accurate structures. In addition, it yields
structural features that are in agreement both with the solid state and the solution state of the same
molecule. This feature may be precious, for instance, when using the resulting structure as a starting
point for molecular simulations or docking studies.
Biomolecules 2019, 9, 370 7 of 12
Figure 3. Calculated versus observed RDCs for ubiquitin (A,B) and GB3 (C,D) before (A,C) and after
(B,D) joint refinement against RDCs and X-ray data. The empty symbols in (B) show the values for
residues 8 and 72. Reproduced with permission from Ref. [101]
Supplementary Materials: The following are available online at http://www.mdpi.com/2218-273X/9/8/370/s1,
Figure S1: Cryo-EM micrograph and 2D classes of free ANSII (right) and ANSII PEGylated with PEG 5000 (left),
Figure S2: Fit of the experimental RDC values collected in the presence of filamentous phages Pf1 (used as
alignment medium) to the structural model with the lowest haddock-score calculated implementing either (A)
only experimental SSNMR restraints (Qfactor 0.29), or (B) experimental SSNMR restraints together with RDCs
(Qfactor 0.14) in HADDOCK 2.2, Table S1: Tensor parameters of the RDCs collected in the presence of filamentous
phages Pf1 to the calculated structural models with the lowest haddock-scores. Table S2: HADDOCK statistics
evaluated on the 200 water refined models of ANSII implementing either only experimental SSNMR restraints or
experimental SSNMR restraints together with RDCs. The reported data are related to the best four structural
models of the two main clusters with the lowest HADDOCK-scores.
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